Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients.

NCT04564898 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Metastatic

Interventions

DRUG: Capecitabine
DRUG: Bevacizumab
DRUG: Trifluridine/Tipiracil

Sponsor

Gruppo Oncologico del Nord-Ovest